Progressive fibrosis and calcification of bladder, ureters, and genital tract
Sandy patches — calcified eggs embedded in submucosal tissues
Complications and carcinogenesis
Obstructive uropathy from ureteral fibrosis — hydroureter and hydronephrosis
Renal failure in advanced disease with cortical atrophy
Squamous cell carcinoma via chronic inflammation and oxidative stress
Upregulation of NF-kB, COX-2, and reactive oxygen species
DNA damage from egg-derived molecules and host inflammatory response
Female genital schistosomiasis — fibrosis of fallopian tubes, cervix, vagina
Increased HIV susceptibility via mucosal disruption
Infertility and ectopic pregnancy risk
CNS disease — ectopic egg embolization to spinal cord or brain
Granulomatous myelitis of conus medullaris most common spinal pattern
Cerebral involvement less common
Therapeutic Considerations
Evidence base for praziquantel
Highly effective against adult worms — WHO essential medicine
60 to 90% parasitological cure rates in clinical trials
Mass drug administration programs reduce morbidity in endemic areas
2022 WHO guidelines recommend preventive chemotherapy for school-age children
No commercially available vaccine — praziquantel remains primary intervention
Treatment monitoring
Urine re-examination at 4 weeks post-treatment for persistent egg shedding
Re-treat if eggs still present at 4 weeks
Serology remains positive months to years — not useful for cure confirmation
CAA or serum PCR are preferred post-treatment markers
PCR negativity by approximately 12 months post-treatment indicates cure
Reversibility of disease with treatment
Early bladder wall thickening and hydronephrosis resolve well after treatment
Calcifications may persist even after parasitological cure
Advanced fibrosis, especially genital tract, may not fully resolve
Bladder cancer risk persists even after treatment of infection
Prevention and public health
Avoid freshwater contact in endemic areas — no chemoprophylaxis available
No licensed vaccine — multiple candidates in clinical trials
Mass drug administration reduces prevalence and disease burden
Safe water, sanitation, and hygiene (WASH) programs reduce transmission
Screen household members and travel companions with shared exposure
Patient Discharge Instructions
copy discharge instructions
Diagnosis and cause
You have been diagnosed with genitourinary schistosomiasis — a parasitic infection caused by a blood fluke called Schistosoma haematobium
You acquired this infection through contact with freshwater in an area where this parasite is present
The parasite causes inflammation and damage to the bladder, ureters, and reproductive organs over time
Medications
Take praziquantel (Biltricide) as prescribed — three doses in one day, separated by 4 to 6 hours
Take with food to reduce nausea and improve absorption
Do not chew the tablets — swallow whole, as they are very bitter
Common side effects: stomach pain, nausea, dizziness, headache — these usually pass within a few hours
Complete the full course even if you feel better
Follow-up required
Return to your doctor in 4 weeks for a repeat urine test to check if the infection has cleared
You may need a second course of treatment if eggs are still present in the urine
A repeat ultrasound of the kidneys and bladder may be arranged in 3 to 6 months
If you have not already been referred, ask about a urology or infectious disease appointment
Prevention of re-infection
Avoid all freshwater contact in endemic areas — no swimming, bathing, wading, or washing in rivers, lakes, or canals in affected regions
There is no vaccine or medication to prevent infection
Bottled or boiled water for drinking and bathing is safe
Return to the emergency department immediately if you experience
Worsening blood in your urine, especially in large amounts
Severe flank or side pain, or markedly reduced urine output
Leg weakness, numbness, or difficulty walking
Inability to urinate
Fever above 38.5 C with chills
Unexplained weight loss or a lump felt in the lower abdomen or pelvis
Other important information
Family members or travel companions who had the same freshwater exposure should be tested
Long-term bladder cancer surveillance may be recommended if you had a prolonged or heavy infection
HIV testing is recommended as this infection can increase susceptibility to HIV
References
Guidelines and key sources
Buonfrate D, Ferrari TCA, Adegnika AA, Russell Stothard J, Gobbi FG — Human Schistosomiasis — Lancet 2025 — PMID 39986748
Comprehensive 2025 Lancet review covering pathophysiology, diagnostics, and treatment
Source for epidemiology, female genital schistosomiasis, and HIV interactions
Lo NC, Bezerra FSM, Colley DG et al — Review of 2022 WHO Guidelines on the Control and Elimination of Schistosomiasis — Lancet Infectious Diseases 2022 — PMID 35594896
Primary WHO guideline review for mass drug administration and treatment recommendations
Basis for praziquantel dosing and treatment monitoring recommendations
Ross AG, Bartley PB, Sleigh AC et al — Schistosomiasis — New England Journal of Medicine 2002 — NEJM
Landmark NEJM review covering life cycle, clinical features, and management
Source for genital schistosomiasis, treatment side effects, and complications
Gryseels B, Polman K, Clerinx J, Kestens L — Human Schistosomiasis — Lancet 2006 — PMID 16997665
Major review covering diagnostics, serology sensitivity, and treatment outcomes
Source for serology performance characteristics and transplant-related persistence
Colley DG, Bustinduy AL, Secor WE, King CH — Human Schistosomiasis — Lancet 2014 — PMID 24698483
CAA testing evidence and real-time PCR diagnostic performance
Source for circulating anodic antigen and PCR sensitivity data
Straily A and Secor WE — Schistosomiasis — CDC Yellow Book 2025 — CDC
Practical travel medicine guidance for praziquantel dosing, prevention, and re-exposure counseling
Shebel HM, Elsayes KM et al — Genitourinary Schistosomiasis: Life Cycle and Radiologic-Pathologic Findings — Radiographics 2012 — PMID 22786992
Primary source for CT and ultrasound imaging findings including ureteral calcifications
Tamarozzi F, Mazzi C, Antinori S et al — Consensus Definitions in Imported Human Schistosomiasis — Lancet Infectious Diseases 2024 — PMID 38467128
GeoSentinel and TropNet Delphi consensus on case definitions for imported disease
Kim MJ, Ryu K, Jin Y et al — Significance of Echogenic Snow Sign as an Ultrasonography Finding — American Journal of Tropical Medicine and Hygiene 2016 — PMID 27549638
Evidence for echogenic snow sign as a diagnostic ultrasound criterion
La Hoz RM, Morris MI, AST Infectious Diseases Community of Practice — Intestinal Parasites Including Schistosomiasis — Clinical Transplantation 2019
Guidelines for schistosomiasis management in solid organ transplant recipients
Ochodo EA et al — Circulating Antigen Tests and Urine Reagent Strips for Diagnosis of Active Schistosomiasis — Cochrane Database of Systematic Reviews 2015
Cochrane evidence base for POC-CCA and dipstick screening performance
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.